Clinical Trials
74 trialsISG-MCS
Italian Sarcoma Group
ISG-ARTICLE
Italian Sarcoma Group
T-DIS
Centre Oscar Lambret
PIPER
Institut Bergonié
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
M.D. Anderson Cancer Center
TRABEPIO
Mario Negri Institute for Pharmacological Research
U01CA236220
Sarcoma Alliance for Research through Collaboration
Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma
University of Michigan Rogel Cancer Center
INVINCIBLE-3
Intensity Therapeutics, Inc.
Trabectedin for Recurrent Grade II/III Meningioma
European Organisation for Research and Treatment of Cancer - EORTC
TRABTRAP
Universität Münster
L-UteCIN
UNICANCER
COMPASS
North Eastern German Society of Gynaecological Oncology
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Sarcoma Oncology Research Center, LLC
TNT
Sarcoma Oncology Research Center, LLC
TAGGED
Sarcoma Oncology Research Center, LLC
MANTRA
Rain Oncology Inc
STRADA
Italian Sarcoma Group
NCT-PMO-1603
National Center for Tumor Diseases, Heidelberg
Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
M.D. Anderson Cancer Center
TRASTS
Grupo Espanol de Investigacion en Sarcomas
OLATRASTS
Grupo Espanol de Investigacion en Sarcomas
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
HyperTET
Ludwig-Maximilians - University of Munich
NiTraSarc
University Medicine Greifswald
Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Fred Hutchinson Cancer Center
Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian Cancer
AGO Research GmbH
INOVATYON
Mario Negri Institute for Pharmacological Research
TRAVELL
Italian Sarcoma Group
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma
Presage Biosciences
MITO23
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MITO 26
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
TOMAS
Italian Sarcoma Group
Trabectedin Maintenance Post 1st-line in STS
European Organisation for Research and Treatment of Cancer - EORTC
ATREUS
Mario Negri Institute for Pharmacological Research
Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Mario Negri Institute for Pharmacological Research
Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma
Fred Hutchinson Cancer Center
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Janssen Research & Development, LLC
Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma
University of Miami
Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors
University of Colorado, Denver
Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors
Children's Oncology Group
TSAR
Gustave Roussy, Cancer Campus, Grand Paris
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
GOG Foundation
A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Xian-Janssen Pharmaceutical Ltd.
TR1US
Italian Sarcoma Group
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
GOG Foundation
TAUL
Mario Negri Institute for Pharmacological Research
Tabectedin to Treat Children and Adolescents With Cancer
National Institutes of Health Clinical Center (CC)
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Janssen Research & Development, LLC
A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction
Janssen Research & Development, LLC